Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCullinan Oncology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | -$0.73 | -$0.73 | -$0.73 |
| Q2 2024 | 3 | -$0.79 | -$0.79 | -$0.79 |
| Q3 2024 | 8 | -$1.06 | -$0.72 | -$0.79 |
| Q1 2025 | 3 | -$0.99 | -$0.70 | -$0.82 |
| Q2 2025 | 2 | -$0.79 | -$0.79 | -$0.79 |
| Q3 2025 | 2 | -$0.79 | -$0.79 | -$0.79 |
| Q4 2025 | 2 | -$0.80 | -$0.80 | -$0.80 |
| Q1 2026 | 1 | -$0.63 | -$0.63 | -$0.63 |
| Q2 2026 | 1 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2026 | 1 | -$0.68 | -$0.68 | -$0.68 |
| Q4 2026 | 1 | -$0.73 | -$0.73 | -$0.73 |
Cullinan Oncology, Inc. Earnings Date And Information
Cullinan Oncology, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.69 earnings per share for the quarter, topping analysts' consensus estimates of $-0.78 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cullinan Oncology, Inc. has generated $-4 earnings per share over the last year ($-3.69 diluted earnings per share) and currently has a price-to-earnings ratio of -4.71. Cullinan Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Cullinan Oncology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.78 | -$0.70 | 0.08 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.73 | -$0.76 | -0.03 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$0.86 | $0 | |||
| 03/14/2024 | Q4 2023 | -$0.96 | -$0.56 | 0.4 | $0 | |
| 11/08/2023 | Q3 2023 | -$0.91 | -$0.92 | -0.01 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.99 | -$0.81 | 0.18 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.84 | -$1.42 | -0.58 | $0 | |
| 03/09/2023 | Q4 2022 | -$0.65 | -$0.59 | 0.06 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.97 | -$0.55 | 0.42 | $0 | |
| 08/10/2022 | Q2 2022 | $5.47 | $3.90 | -1.57 | $275.00 M | $0 |
| 05/16/2022 | Q1 2022 | -$0.61 | -$0.29 | 0.32 | $0 | |
| 03/17/2022 | Q4 2021 | -$0.47 | -$0.76 | -0.29 | $-37,848,114 | |
| 11/09/2021 | Q3 2021 | -$0.42 | -$0.40 | 0.02 | $0 | |
| 08/10/2021 | Q2 2021 | -$0.36 | $0 | |||
| 05/14/2021 | Q1 2021 | $0.07 | -$0.00 | -0.07 | $18.94 M | |
| 03/30/2021 | Q4 2020 | -$0.38 | -$0.68 | -0.3 | $0 | |
| 09/29/2020 | Q3 2020 | -$0.26 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.45 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.26 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.24 | $0 |
Cullinan Oncology, Inc. Earnings: FAQ's
When is Cullinan Oncology, Inc.'s earnings date?
Cullinan Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
Did Cullinan Oncology, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Cullinan Oncology, Inc. (:CGEM) reported $-0.69 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.78 by $0.09.
How can I listen to Cullinan Oncology, Inc.'s earnings conference
call?
The conference call for Cullinan Oncology, Inc.'s latest earnings report can be listened to online.
How can I read Cullinan Oncology, Inc.'s conference call transcript?
The conference call transcript for Cullinan Oncology, Inc.'s latest earnings report can be read online.
How much profit does Cullinan Oncology, Inc. generate each year?
Cullinan Oncology, Inc. (:CGEM) has a recorded net income of $0. Cullinan Oncology, Inc. has generated $-3.69 earnings per share over the last four quarters.
What is Cullinan Oncology, Inc.'s price-to-earnings ratio?
Cullinan Oncology, Inc. (:CGEM) has a price-to-earnings ratio of -4.71 and price/earnings-to-growth ratio is -0.66.